سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Development of 177Lu-phytate Complex for Radiosynovectomy

Publish Year: 1392
Type: Journal paper
Language: English
View: 295
این Paper فقط به صورت چکیده توسط دبیرخانه ارسال شده است و فایل کامل قابل دریافت نیست. برای یافتن Papers دارای فایل کامل، از بخش [جستجوی مقالات فارسی] اقدام فرمایید.

Export:

Link to this Paper:

Document National Code:

JR_IJBMS-16-5_008

Index date: 26 October 2021

Development of 177Lu-phytate Complex for Radiosynovectomy abstract

Objective(s): In this work a new possible agent for radiosynovectomy has been targeted for articular pain palliation. Materials and Methods: Lu-177 of 2.6-3 GBq/mg specific activity was obtained by irradiation of natural Lu2O3 sample with thermal neutron flux of 4 × 1013 n.cm-2.s-1. The product was converted into chloride form which was further used for labeling of 177Lu-phytate complex and checked using ITLC (MeOH: H2O: acetic acid, 4: 4: 2, as mobile phase). The complex stability and viscosity were checked in the final solution up to seven days. The prepared complex solution (100 µCi/100 µl) was injected intra-articularly to male rat knee joint. Leakage of radioactivity from injection site and its distribution in organs were investigated up to seven days. Results: The complex was successfully prepared with high radiochemical purity (>99.9 %). Approximately, the whole injected dose has remained in injection site seven days after injection. Conclusion: The complex was proved to be a feasible agent for cavital radiotherapy in oncology and rheumatology

Development of 177Lu-phytate Complex for Radiosynovectomy Keywords:

Biodistribution Lutetium-177 Phytate Radiosynovectomy

Development of 177Lu-phytate Complex for Radiosynovectomy authors

Hassan Yousefnia

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran, P.O.Box:۱۴۳۹۵-۸۳۶ ۲ Faculty of Energy Engineering and Physics, Amirkabir University of Technology. Tehran, Iran

Amir Reza Jalilian

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran, P.O.Box:۱۴۳۹۵-۸۳۶

Ali Bahrami-Samani

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran, P.O.Box:۱۴۳۹۵-۸۳۶

Mohammad Mazidi

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran, P.O.Box:۱۴۳۹۵-۸۳۶

Mohammad Ghannadi Maragheh۱

Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran, P.O.Box:۱۴۳۹۵-۸۳۶

Fereydoun Abbasi-Davani

Radiation Application Group, Faculty of Nuclear Engineering, Shahid Beheshti University, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
European Association of Nuclear Medicine (EANM)Procedure guidelines for radiosynovectomy, Guidelines ...
Kropácek M, Melichar F, Henková K, Konopková M. Preparation of ...
Suzuki YS, Momose Y, Higashi N, Shigematsu A, Park KB, ...
Bodei L, Ferone D, Grana CM, Cremonesi M, Signore A, ...
Michel RB, Andrews PM, Rosario AV, Goldenberg DM, Mattes MJ. ...
Breitz H, Wendt R, Stabin M, Bouchet L, Wessels B. ...
Chakraborty S, Das T, Sarma HD, Venkatesh M, Banerjee S. ...
Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M. ...
Manual for reactor produced radioisotopes, IAEA, Vienna, ۲۰۰۳, IAEA- TECDOC-۱۳۴۰, ...
نمایش کامل مراجع